Data and interpretation: Economic evaluations in transfusion medicine, Part 4

Transfusion

Volumn 53, Issue 10, 2013, Pages 2130-2133

  Kacker, Seema ^b   Frick, Kevin D ^b   Tobian, Aaron A R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAFETY; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; MONTE CARLO METHOD; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

BLOOD SAFETY; COST-BENEFIT ANALYSIS; HUMANS; TRANSFUSION MEDICINE;

EID: 84885868375     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12185     Document Type: Article

References (11)

1. Kacker S, Frick KD, Tobian A,. Costs of transfusion: economic evaluations in transfusion medicine, Part 1. Transfusion 2013; 53: 1383-1385
2. Kacker S, Frick KD, Tobian A,. Establishing a framework: economic evaluations in transfusion medicine, Part 2. Transfusion 2013; 53: 1634-1636
3. Kacker S, Frick KD, Tobian A,. Constructing a model: economic evaluations in transfusion medicine, Part 3. Transfusion 2013; 53: 1885-1887
4. Drummond MF,. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford; New York: Oxford University Press; 2005.
5. Jain R, Grabner M, Onukwugha E,. Sensitivity analysis in cost-effectiveness studies: from guidelines to practice. Pharmacoeconomics 2011; 29: 297-314.
6. Briggs AH,. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479-500. (Pubitemid 30398806)
7. Briggs AH, Gray AM,. Handling uncertainty in economic evaluations of healthcare interventions. BMJ 1999; 319: 635-638. (Pubitemid 29414568)
8. Custer B,. Economic analyses of blood safety and transfusion medicine interventions: a systematic review. Transfus Med Rev 2004; 18: 127-143. (Pubitemid 38501238)
9. AuBuchon JP, Birkmeyer JD, Busch MP,. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997; 37: 45-51. (Pubitemid 27068939)
10. Jackson BR, Busch MP, Stramer SL, AuBuchon JP,. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-729. (Pubitemid 36629116)
11. Blumberg N, Heal JM,. Mortality risks, costs, and decision making in transfusion medicine. Am J Clin Pathol 2000; 114: 934-937. (Pubitemid 33051894)